Approach to infected skin ulcers

Canadian Family Physician

Volumn 51, Issue OCT., 2005, Pages 1352-1359

  Frank, Christopher ^a   Bayoumi, Imaan ^b   Westendorp, Claire ^b  

^a St Mary's of the Lake Hospital   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTICOAT 7; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AQUACEL AG; BACITRACIN; CADEXOMER IODINE; CARBOXYMETHYLCELLULOSE; CEFALEXIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; CYTOTOXIC AGENT; DIHYDROMORPHINE; FENTANYL; FUSIDATE SODIUM; GENTAMICIN; GRAMICIDIN; LODOSORB; METRONIDAZOLE; NANOCRYSTALLINE SILVER; NEOMYCIN; POLYMYXIN B; POVIDONE IODINE; PSEUDOMONIC ACID; SILVER DERIVATIVE; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CONTAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPUTER PROGRAM; DEBRIDEMENT; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRANULATION TISSUE; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; LABORATORY TEST; MEDICAL SOCIETY; MEDLINE; NONHUMAN; PAIN; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKIN INFECTION; SKIN ULCER; SYSTEMATIC REVIEW; TREATMENT FAILURE; WOUND CARE; WOUND DRESSING; WOUND INFECTION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; HUMANS; IODINE; MALE; SILVER; SKIN ULCER; VARICOSE ULCER; WOUND INFECTION;

EID: 27744502607     PISSN: 0008350X     EISSN: 0008350X     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Graham ID, Harrison MB, Shafey M, Keast D. Knowledge and attitudes regarding care of leg ulcers. Survey of family physicians. Can Fam Physician 2003;49:896-902.
2. Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D, International Wound Bed Preparation Advisory Board, Canadian Chronic Wound Advisory Board. Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 2003;49(11):23-51.
3. Registered Nurses Association of Ontario. Assessment and management of stage I to IV pressure ulcers. Toronto, Ont: Registered Nurses Association of Ontario; 2002.
4. Dolynchuk K, Keast D, Campbell K, Houghton P, Orstead H, Sibbald G, et al. Best practices for the prevention and treatment of pressure ulcers. Ostomy Wound Manage 2000;46(11):38-52.
5. Bergstrom N Bennett M, Carlson CE, et al. Treatment of pressure ulcers. Clinical practice guideline No. 15. Rockville, Md: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 95-0652. 1994.
6. O'Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg 2001;88(1):4-21.
7. Wysocki AB. Evaluating and managing open skin wounds: colonization versus infection. AACN Clin Issues 2002;13(3):382-97.
8. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14(2):244-69.
9. Bowler PG, Davies BJ. The microbiology of infected and non-infected leg ulcers. Int J Dermatol 1999;38(8):573-8.
10. Nichols RL, Smith JW. Anaerobes from a surgical perspective. Clin Infect Dis 1994;18(Suppl 4):S280-S286.
11. Dow G, Browne A, Sibbald RG. Infection in chronic wounds: controversies in diagnosis and treatment. Ostomy Wound Manage 1999;45(8):23-40.
12. Sapico FL, Ginunas VJ, Thornhill-Joynes M, Canawati HN, Capen DA, Klein NE, et al. Quantitative microbiology of pressure sores in different stages of healing. Diagn Microbiol Infect Dis 1986;5(1):31-8.
13. Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004;9(3):S6-15.
14. Gardner SE, Frantz RA, Doebbeling BN. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 2001;9(3):178-86.
15. Gardner SE, Frantz RA, Troia C, Eastman S, MacDonald M, Buresh K, et al. A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy Wound Manage 2001;47(1):40-7.
16. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273(9):721-3.
17. Trengove NJ, Stacey MC, McGechie DF, Mata S. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996;5(6):277-80.
18. O'Neill MA, Vine GJ, Beezer AE, Bishop AH, Hadgraft J, Labetoulle C, et al. Antimicrobial properties of silver-containing wound dressings: a microcalorimetric study. Int J Pharm 2003;263(1-2):61-8.
19. Sibbald RG, Browne AC, Coutts P, Queen D. Screening evaluation of an ionized nanocrystalline silver dressing in chronic wound care. Ostomy Wound Manage 2001;47(10):38-43.
20. Pennie RA. Which antibiotic to choose? Hamilton, Ont: McMaster University; 2000.
21. Pennie RA. Cephalosporin confusion. Hamilton, Ont: McMaster University; 2000.
22. Antibiotic Subcommittee of the Pharmacy and Therapeutics Committee. Guidelines for antimicrobial use. Toronto, Ont: University Health Network; 2001. p. 89-90.
23. Evans G, McKenna S. The Kingston Hospitals Antimicrobial Handbook. 3rd ed. Kingston, Ont: Antimicrobial Use Working Group Pharmaceuticals and Therapeutics Committee; 2003.
24. Romanelli M, Magliaro A, Mastronicola D, Siani S. Systemic antimicrobial therapies for pressure ulcers. Ostomy Wound Manage 2003;49(5A Suppl):25-9.